GI Hep

Child–Pugh classification for cirrhosis prognosis (encephalopathy, ascites, bilirubin, albumin, INR).

3-variable MELD score estimating 90-day mortality in advanced liver disease.

MELD with serum sodium to better capture risk from hyponatremia.

Adds albumin, sex, dialysis to MELD-Na; refined transplant prioritization.

UK Model for End-Stage Liver Disease; UK allocation metric.

Simple signal for alcoholic liver disease vs viral/NAFLD context.

NAFLD fibrosis risk (BMI, AST/ALT, diabetes).

Age, AST, ALT, platelets to triage risk of advanced fibrosis.

Noninvasive score (age, BMI, DM, AST/ALT, platelets, albumin) for advanced fibrosis in NAFLD.

ACLF mortality prediction using organ failure assessment.

External tool for data-driven DILI causality assessment.

HCC detection model (Gender, Age, AFP, AFP-L3, DCP).

Glasgow Alcoholic Hepatitis Score for short-term mortality.

Acute liver failure transplant criteria (APAP vs non-APAP).

Early response to steroids in alcoholic hepatitis at day 7.

Maddrey Discriminant Function for alcoholic hepatitis severity.

Crohn’s Disease Activity Index (symptoms, Hct, weight, meds).

Simplified Crohn’s activity score (stools, pain, well-being, mass, complications).

Ulcerative Colitis activity index (stool frequency, bleeding, endoscopy, physician assessment).

Upper GI bleed risk (Hb, BUN, BP, HR, melena/syncope/comorbidity).

Major bleeding risk score (AF anticoagulation context).

Stool form types 1–7; proxy for transit time and bowel habit patterns.

Admission + 48h criteria for acute pancreatitis severity/mortality.

Body Mass Index with standard and SI units.

IBW via Devine/Robinson/Miller/Lemmens formulas.